OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration
Can Chen, Tongyu Li, Yiwei Li, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24857-e24857
Open Access | Times Cited: 5
Can Chen, Tongyu Li, Yiwei Li, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24857-e24857
Open Access | Times Cited: 5
Showing 5 citing articles:
Cellular mechanisms of early brain overgrowth in autistic children: elevated levels of GPX4 and resistance to ferroptosis
Siwei Chen, Anna Shcherbina, Simon T. Schafer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Siwei Chen, Anna Shcherbina, Simon T. Schafer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Construction of regulatory T cells specific genes predictive models of prostate cancer patients based on machine learning: a computational analysis and in vitro experiments
Zhengrong Zhou, Chang Yin Liang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Zhengrong Zhou, Chang Yin Liang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
DLD is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients
Can Chen, Dandan Kang, Zhenzhen Chen, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1696-1708
Open Access | Times Cited: 1
Can Chen, Dandan Kang, Zhenzhen Chen, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1696-1708
Open Access | Times Cited: 1
SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients
Can Chen, Yun Li, Yiwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1454-1465
Open Access | Times Cited: 1
Can Chen, Yun Li, Yiwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1454-1465
Open Access | Times Cited: 1
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access | Times Cited: 1
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access | Times Cited: 1
